Anticancer agent 265
Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values of 13.1, 11.7, and 14.6 μM, respectively[1].
Product Specifications
CAS Number
184177-83-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Purity
99.74
Smiles
O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C
Molecular Formula
C30H35N5O3
Molecular Weight
513.63
Precautions
H302, H315, H319, H335
References & Citations
[1]G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1- ((2S, 3S) -2- (benzyloxy) pentan-3-yl) -4- (4- (4- (4-hydroxyphenyl) piperazin-1-yl) phenyl) -1H-1, 2, 4-triazol-5 (4H) -one. Journal of Structural Chemistry 60.7 (2019) : 1173-1179.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2188206 1.0 µg DNA
SLC37A4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details MBS1227666-01 0.02 mg (E-Coli)
Recombinant Pyrococcus horikoshii Uncharacterized ATP-binding protein PH0541 (PH0541)
Sign In for Pricing
View Details